Angiotensin II type 1a receptor-deficient mice develop angiotensin II-induced oxidative stress and DNA damage without

Anna Zimnol1, Kerstin Amann2, Philipp Mandel1

  • 1Institute of Toxicology, Medical Faculty, University of Düsseldorf, Düsseldorf, Germany; and.

Insights

Angiotensin II causes DNA damage and reactive oxygen species (ROS) production, even without increasing blood pressure. This study investigates the role of blood pressure in angiotensin II-induced genomic damage.

Area of Science:

  • Cardiovascular Research
  • Nephrology
  • Molecular Biology

Background:

  • Hypertension is linked to increased kidney cancer risk.
  • Angiotensin II is known to elevate blood pressure and cause DNA damage.
  • The specific role of blood pressure in this damage requires further elucidation.

Purpose of the Study:

  • To investigate the role of blood pressure in angiotensin II-induced DNA damage.
  • To differentiate the effects of angiotensin II on oxidative stress and DNA damage independent of hypertension.
  • To examine the involvement of angiotensin II type 1 receptor (AT1R) subtypes in these processes.

Main Methods:

  • Utilized AT1aR-knockout mice and wild-type mice treated with angiotensin II.
  • Administered angiotensin II via osmotic minipumps for 28 days.
  • Assessed parameters of oxidative stress, DNA damage (including double-strand breaks), blood pressure, and kidney function.

Main Results:

  • In wild-type mice, angiotensin II caused hypertension, reduced kidney function, increased reactive oxygen species (ROS), and genomic damage.
  • Candesartan treatment attenuated these angiotensin II effects in wild-type mice.
  • In AT1aR-knockout mice, angiotensin II increased ROS and induced genomic double-strand breaks without affecting blood pressure or kidney function.

Conclusions:

  • Angiotensin II induces ROS production and DNA damage independently of blood pressure elevation.
  • The AT1aR subtype is not essential for angiotensin II-induced ROS production and DNA damage.
  • These findings highlight a direct mechanism of angiotensin II in causing cellular damage relevant to kidney disease and cancer risk.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.2K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.8K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.1K